Effectiveness of the RAUC Pathway in Reducing Unscheduled Hospitalizations After Emergency Digestive Surgery (RAUCAMIENS)

Effectiveness of the Augmented Rehabilitation of Digestive Surgical Emergencies Pathway in Reducing Unscheduled Hospitalizations After Surgery

The number of emergencies's visits (22 million visits in 2019 in France), the organization of emergencies and the sustainability of the current health system are threatened. In the CHUAP adult emergency department, 60,000 visits were recorded in 2022.

Unlike medical emergencies which have structured their care and research activities (heart, brain), and whose organization has demonstrated its general interest for society, digestive surgical emergencies, which involve complex patients (elderly people, comorbidities) , emergency situations and surgical procedures, have never been thought of globally in terms of personalized care and research pathways. Currently, patients treated in emergency are managed without a pre-established optimization program and without a dedicated pathway, where emergency constitutes a major risk factor for postoperative complications.

RAUCAMIENS evaluates a new care pathway implemented within the framework of the RHU RAUC : the implementation of the Enhanced rehabilitation after surgery (ERAS) and e-health devices for home monitoring, for patients treated in the emergency room for a digestive pathology. The purpose is to evaluate the effectiveness of the RAUC pathway in reducing the rate of unplanned hospitalization readmission after emergency digestive surgery 30 days postoperative.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

3000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Rouen, France, 76000
        • Recruiting
        • CHU Rouen
      • Salouel, France, 80480

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Criterion linked to the protocol :

    -- Patient consulted in emergency for a digestive pathology requiring surgery

  • Search criteria:

    • Adult patient (≥ 18 years old),
    • Able to give consent,
    • Affiliation to a social security scheme

Exclusion Criteria:

  • Criterion linked to the protocol:

    • Patient leaving hospitalization to a convalescent center
    • Patient requiring direct operating room (vital emergency or surgical revision)
    • Patient presenting to the emergency room for a postoperative complication
    • Patient directly admitted to intensive care
  • Search criteria:

    • Pregnant or breastfeeding woman
    • Patient under guardianship, curatorship or deprived of liberty

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
patients included in the CHUAP RAUC + course
ERAS
teleexpertise solution connecting extra-hospital and intra-hospital practitioners
virtual reality headset to reduce anxiety
patch to continuously monitor patients' physiological parameters at home
digital solution for managing patients at home
taking CRP at home
recording of the different operating times
Active Comparator: Control group 1
patients from CHU Rouen included over the same period as patients from CHUAP benefiting from standard care (RAUC -)
ERAS
Active Comparator: Control group 2
patients verifying the inclusion/non-inclusion criteria and from the SNDS over the period from January 1, 2022 to December 31, 2025
ERAS

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Occurrence of an unscheduled hospitalization readmission
Time Frame: 30 days
Occurrence of an unscheduled hospitalization readmission following digestive surgery performed urgently within 30 days
30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clavien-Dindo score
Time Frame: 30 days
30 days
Duration of hospitalization linked to the first admission to perform emergency digestive surgery
Time Frame: 30 days
Duration of hospitalization linked to the first admission to perform emergency digestive surgery
30 days
Quality of life score
Time Frame: 0 day
Quality of life assessed by the scores of the different dimensions of the EQ-5D-5L which is a PROMS, at admission
0 day
Quality of Life score
Time Frame: 30 days
Quality of life assessed by the scores of the different dimensions of the EQ-5D-5L which is a PROMS
30 days
STAI-Y scale
Time Frame: 0 day
Anxiety assessed by the STAI-Y scale
0 day
Transition to emergency without hospitalization
Time Frame: 30 days
Transition to emergency without hospitalization
30 days
incremental cost-utility ratio
Time Frame: 30 days
incremental cost-utility ratio
30 days
incremental cost-effectiveness ratio
Time Frame: 30 days
incremental cost-effectiveness ratio (cost per readmission avoided)
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jean Marc Regimbeau, Pr, CHRU Amiens

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 2, 2025

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

August 1, 2027

Study Registration Dates

First Submitted

January 7, 2025

First Submitted That Met QC Criteria

January 7, 2025

First Posted (Actual)

January 10, 2025

Study Record Updates

Last Update Posted (Actual)

June 13, 2025

Last Update Submitted That Met QC Criteria

June 11, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PI2024_843_0094

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Digestive Emergency

Clinical Trials on ERAS

Subscribe